Altamira Therapeutics Market Cap

Altamira Therapeutics has a market cap or net worth of $465.74 thousand as of April 29, 2025. Its market cap has decreased by -87.87% in one year.

Market Cap

465.74K

Enterprise Value

827.72K

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.10

Market Cap Chart

Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 465.74K, a decrease of -99.73%. That is a compound annual growth rate of -42.38%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	465.74K	23.91%
Dec 31, 2024	375.87K	-72.84%
Dec 29, 2023	1.38M	-75.59%
Dec 30, 2022	5.67M	-78.93%
Dec 31, 2021	26.91M	-10.02%
Dec 31, 2020	29.91M	459.11%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Nika Pharmaceuticals	1.02B
Veradigm	746.57M
Glass House Brands	483.81M
Elite Pharmaceuticals	443.14M
Northwest Biotherapeutics	402.45M
CytoDyn	288.39M
BioStem Technologies	245.41M

Market Cap Rankings